Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A microfluidic-integrated lateral flow recombinase polymerase amplification (MI-IF-RPA) assay for rapid COVID-19 detection

1 Jan 2021

Abstract excerpt

The COVID-19 pandemic, caused by SARS-CoV-2, currently poses an urgent global medical crisis for which there remains a lack of affordable point-of-care testing (POCT). In particular, resource-limited areas need simple and easily disseminated testing solutions to manage the outbreak. In this work, a microfluidic-integrated lateral flow recombinase polymerase amplification (MI-IF-RPA) assay was developed for rapid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34008614
DOI: 10.1039/d0lc01222j

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A microfluidic-integrated lateral flow recombinase polymerase amplification (MI-IF-RPA) assay for rapid COVID-19 detectionPMID 34008614Read ↗

Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2Semantic proximity Read ↗

Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acidSemantic proximity Read ↗

Rapid Differential Diagnosis of Influenza A and B Viruses With RT‐RPA Centrifugal Microfluidic ChipSemantic proximity Read ↗

Harnessing recombinase polymerase amplification for rapid detection of SARS-CoV-2 in resource-limited settingsSemantic proximity Read ↗

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic TechnologySemantic proximity Read ↗

Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assaySemantic proximity Read ↗

An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settingsSemantic proximity Read ↗

Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19Semantic proximity Read ↗

Development of a colorimetric RT-LAMP-based microfluidic device for COVID-19 diagnosisSemantic proximity Read ↗

A roadmap to high-speed polymerase chain reaction (PCR): COVID-19 as a technology acceleratorSemantic proximity Read ↗

Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation SequencingSemantic proximity Read ↗

Paper-based RNA detection and multiplexed analysis for Ebola virus diagnosticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.